North Dakota · Telemedicine
Specialized Psychiatric Care in North Dakota
Verigrate Health provides physician-led psychiatric consultation by telemedicine to appropriate patients who are physically located in North Dakota at the time of care. Christian S. Monsalve, M.D., personally evaluates diagnostic uncertainty, complex psychopharmacology, difficult medication histories, and questions that require a careful review of how symptoms and treatment have changed over time.
Consultation may address diagnostic clarification, complex medication review, antidepressant or benzodiazepine-related complexity, deprescribing, or a proposed taper. Medication reduction is considered when clinically appropriate and is not assumed to be the goal of care; recommendations may also support continuing or revising useful treatment.
Clinical Review Across Time
Clarifying Diagnosis, Treatment Response, and Medication Burden
A focused consultation when diagnoses remain uncertain, symptoms persist, earlier explanations conflict, or treatment response does not fit the expected course.
Individual planning when medication reduction requires attention to sequence, prior withdrawal, current stability, medical context, and the broader treatment plan.
Review of benzodiazepine exposure, dependence, tolerance, previous withdrawal, concurrent prescriptions, clinical risk, and the reasons treatment has continued.
Medication-by-medication reassessment of indication, benefit, adverse effects, interactions, cumulative burden, and whether simplification could improve care.
Psychiatric decision-making considered alongside sleep, metabolic health, physical health, substance use, and other medically relevant factors.
Physician consultation for alcohol-related psychiatric complexity, treatment response, medication strategy, evidence-based options, and level-of-care questions.
Medication Stewardship
Psychiatric Medication Tapering in North Dakota
Medication tapering is one possible result of a broader psychiatric assessment, not a predetermined destination. Review begins with the original indication, benefit over time, adverse effects, prior dose changes, withdrawal experiences, current symptoms, concurrent treatment, and the patient’s priorities. When reduction is appropriate, the sequence and pace are designed around clinical stability rather than a generic schedule.
Antidepressant review may include escitalopram (Lexapro), sertraline (Zoloft), fluoxetine (Prozac), venlafaxine (Effexor XR), duloxetine (Cymbalta), bupropion, mirtazapine, and tricyclic antidepressants. Recommendations consider treatment response, duration, withdrawal sensitivity, recurrence risk, and whether present symptoms reflect the illness, the medication, or an earlier dose change.
Alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), diazepam (Valium), and related medicines are reviewed in relation to duration, dependence, prior withdrawal, co-prescribed medications, medical risk, and ongoing benefit. If a taper is appropriate, the pace is individualized and monitored rather than fixed in advance.
Sleep medications and hypnotics
Sleep-focused review may include zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata), orexin receptor antagonists, sedating antidepressants, and other hypnotics. The assessment distinguishes the underlying sleep problem from medication effects, rebound insomnia, withdrawal, and coexisting psychiatric symptoms.
Antipsychotics, mood stabilizers, and ADHD medications
Antipsychotics, lithium and other mood stabilizers, stimulant and non-stimulant ADHD treatments, anxiolytics, adjunctive medicines, and medications used in substance-related care may also be reviewed. The purpose is to understand the complete regimen before deciding what should be preserved, changed, or reconsidered.
Stability Before Simplification
The safest first decision may be to leave part of a regimen unchanged. Recommendations weigh diagnostic clarity, current benefit, adverse effects, withdrawal sensitivity, available support, and the risks of both changing and continuing treatment.
How Care Works
Physician-Led Telepsychiatry for Patients in North Dakota
Appropriate patients may receive specialized psychiatric consultation by secure telemedicine while physically located in North Dakota at the time of the appointment. The work may focus on a complex medication regimen, unresolved diagnosis, difficult treatment history, deprescribing, or a proposed taper while another clinician remains involved when appropriate. Verigrate does not represent a physical North Dakota office and is not an emergency or walk-in service; availability depends on clinical fit and practice capacity.
Practice Structure
Common Questions
Is Verigrate psychiatric consultation available by telemedicine in North Dakota?
Yes. Verigrate provides physician-led psychiatric consultation by secure telemedicine to appropriate patients who are physically located in North Dakota at the time of care. The practice does not claim a physical North Dakota office, hospital affiliation, or walk-in service.
What information is useful for a complex medication review?
A current medication list, the sequence and approximate duration of prior treatments, reasons medications were started or stopped, treatment response, adverse effects, withdrawal experiences, relevant medical history, and available records can help clarify the clinical course. The consultation can still begin when some records are incomplete.
Can tapering be discussed without committing to stop medication?
Yes. A consultation can evaluate whether antidepressant, benzodiazepine, hypnotic, stimulant, antipsychotic, mood-stabilizer, or other psychiatric medication tapering is clinically appropriate without presuming that discontinuation should occur. Continuing treatment may be the better recommendation.
How is benzodiazepine-related complexity evaluated?
The review considers the original indication, duration, dose pattern, dependence, prior withdrawal, co-prescribed medications, medical and psychiatric risk, current benefit, and the patient’s goals. A taper is recommended only when the expected benefits and available supports justify the change.
What happens after an initial psychiatric consultation?
Dr. Monsalve discusses what the history supports, what remains uncertain, and which next steps are clinically appropriate. Recommendations may include obtaining additional information, continuing treatment, revising part of the regimen, coordinating with another clinician, or planning a gradual medication change.